Adtralza (tralokinumab)

pCPA File Number: 21808
Negotiation Status:
Negotiations were not pursued
Indication(s):
atopic dermatitis
Sponsor/Manufacturer:
LEO Pharma Inc.
CDA-AMC Project Number:
SR0689
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: